MITOCHONDRION
Scope & Guideline
Pioneering Discoveries in Mitochondrial Function
Introduction
Aims and Scopes
- Mitochondrial Dynamics and Functionality:
Research on the mechanisms governing mitochondrial dynamics, including fusion, fission, and transport, and their implications for cellular energy metabolism and homeostasis. - Mitochondrial Genetics and Genomics:
Studies investigating mitochondrial DNA mutations, heteroplasmy, and their associations with various diseases, including neurodegenerative disorders and metabolic syndromes. - Mitochondrial Metabolism and Bioenergetics:
Explorations of mitochondrial metabolic pathways, such as the Krebs cycle and oxidative phosphorylation, and their roles in cellular energy production and metabolic reprogramming. - Mitochondrial Dysfunction in Disease:
Research highlighting the contribution of mitochondrial dysfunction to a range of diseases, including cancer, diabetes, neurodegenerative disorders, and cardiovascular diseases. - Therapeutic Interventions Targeting Mitochondria:
Innovative approaches to target mitochondrial function for therapeutic benefits, including mitochondrial transplantation, pharmacological agents, and gene therapies. - Environmental and Physiological Impacts on Mitochondria:
Studies examining how environmental factors, such as hypoxia and oxidative stress, affect mitochondrial function and contribute to disease pathology.
Trending and Emerging
- Mitochondrial Transfer and Transplantation:
An increasing focus on the therapeutic potential of mitochondrial transfer and transplantation techniques for treating diseases, particularly in regenerative medicine and organ repair. - Mitochondrial Role in Neurodegenerative Diseases:
A growing body of research is dedicated to understanding the role of mitochondrial dysfunction in neurodegenerative diseases, with implications for new therapeutic strategies and patient management. - Mitochondrial Metabolism and Cancer Therapy:
Emerging studies are exploring how targeting mitochondrial metabolism can influence cancer treatment outcomes, particularly in the context of metabolic reprogramming and drug resistance. - Mitochondrial Dynamics as Therapeutic Targets:
Research increasingly emphasizes the importance of mitochondrial dynamics (fusion, fission, and mitophagy) in disease contexts, suggesting that modulating these processes could offer new therapeutic avenues. - Mitochondrial Biomarkers in Disease Diagnosis:
There is a rising interest in identifying mitochondrial DNA variations and other mitochondrial-related biomarkers for the diagnosis and prognosis of various diseases, including metabolic disorders and cancers. - Machine Learning and Artificial Intelligence in Mitochondrial Research:
The integration of machine learning and AI techniques to analyze mitochondrial data is gaining traction, enhancing the capacity for high-throughput analysis and predictive modeling in mitochondrial biology.
Declining or Waning
- Basic Mitochondrial Structure Studies:
Research primarily focused on the structural aspects of mitochondria, such as ultrastructure without functional implications, has seen a decline as the field moves towards more integrative functional studies. - Mitochondrial Research in Non-Mammalian Models:
While non-mammalian models (like yeast and plants) have contributed significantly to mitochondrial research, there seems to be a waning interest in this area compared to mammalian studies that directly apply to human health. - Static Mitochondrial Imaging Techniques:
The use of traditional imaging techniques to study mitochondria in fixed states is diminishing as advanced live-cell imaging and dynamic tracking methods gain favor for their ability to capture real-time mitochondrial behavior.
Similar Journals
AGING CELL
Exploring the Frontiers of Aging ResearchAGING CELL is a premier peer-reviewed journal published by Wiley, specializing in the rapidly evolving field of aging research and cell biology. Established in 2002 and enjoying an impressive track record as evidenced by its Q1 ranking in both Aging and Cell Biology categories for 2023, the journal has become a vital resource for researchers and professionals alike. With a significant impact factor highlighting its scholarly influence, AGING CELL offers an open access model since 2014, ensuring that groundbreaking research is accessible to the global community. The journal covers a wide array of topics related to the mechanisms of aging at the cellular and molecular levels, making it essential reading for anyone invested in understanding the complexities of aging processes and their implications for health and disease. With a broad international readership based in the United Kingdom and beyond, AGING CELL is dedicated to disseminating high-quality research that impacts scientific understanding and fosters advances in the field.
ANTIOXIDANTS & REDOX SIGNALING
Advancing the Frontiers of Redox BiologyANTIOXIDANTS & REDOX SIGNALING, published by MARY ANN LIEBERT, INC, is a premier journal dedicated to advancing the understanding of oxidative stress, antioxidants, and redox biology in various health contexts. With an impressive track record since its inception in 1999, this journal has continually evolved, currently converging towards 2024 as a core resource for researchers in biochemistry, cell biology, and molecular medicine. It holds a distinguished position in Q1 across several categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, reflecting its critical role in disseminating high-quality research that impacts the fields of physiology and medicine. Despite not being an open-access journal, ANTIOXIDANTS & REDOX SIGNALING is renowned for its rigorous peer-review process and wide reach, ensuring that published articles are both influential and accessible to professionals, academia, and students alike. Researchers can benefit from its comprehensive articles that delve into cutting-edge discoveries and emerging therapies related to oxidative stress and its biological implications.
Mitochondrial DNA Part A
Navigating the Frontiers of Mitochondrial ScienceMitochondrial DNA Part A, published by Taylor & Francis Ltd, is a distinguished journal dedicated to the exploration of mitochondrial genetics and its implications for health and disease. With an ISSN of 2470-1394 and an E-ISSN of 2470-1408, this journal serves as an open-access platform, promoting the dissemination of high-quality research in the field. Operating from the United Kingdom, it offers a vital resource for researchers and professionals keen to delve into the rapidly evolving landscape of mitochondrial studies. Although currently ranked Q4 in both the Genetics and Molecular Biology categories, the journal continues to be a valuable outlet for emerging findings that could impact our understanding of cellular processes and hereditary conditions. Researchers can access articles and data covering recent advancements from 2016 through 2022, with ongoing contributions expected in 2024. As the field grows, so too does the importance of this journal as a source of knowledge and collaboration for the academic community.
Physiological Reports
Fostering Collaboration through High-Impact ResearchPhysiological Reports is a pioneering open-access journal published by WILEY, dedicated to advancing the field of physiology through the dissemination of high-quality research. Since its inception in 2013, this journal has provided a platform for innovative studies in both general physiology and medical physiology, making significant contributions to our understanding of biological processes. With an impact factor that reflects its growing influence—as evidenced by its placement in the Q2 category for physiology and medical physiology in 2023—Physiological Reports is positioned as a vital resource for researchers and practitioners alike. The journal encourages the submission of diverse studies ranging from cellular mechanisms to systemic physiology, presenting a unique opportunity for authors to reach a global audience without access barriers. It has established a reputation for rigorous peer review and timely publication, ensuring that cutting-edge research is readily available to stimulate further inquiry and collaboration in the scientific community.
BIOCHIMIE
Pioneering Research for Tomorrow's Health SolutionsWelcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
Innovative Research at the Intersection of Life SciencesBIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS is a prestigious journal published by Elsevier, dedicated to advancing the fields of biochemistry, biophysics, and cell biology. Established in 1967, this journal is committed to disseminating high-quality research that unveils the molecular mechanisms of bioenergetics, encompassing a wide range of topics from mitochondrial function to energy metabolism. With an exceptional impact factor and a current ranking in the Q1 quartile across multiple categories—specifically ranked #13 in Biophysics and featuring strong positions in Biochemistry and Cell Biology—this journal is recognized for its influential contributions to the scientific community. Scholars, researchers, and students globally benefit from its rigorous peer-review process and access options, although it is not currently open access. By providing a platform for innovative research, BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS plays a critical role in fostering scientific advancement and collaboration among professionals in the field.
RUSSIAN JOURNAL OF GENETICS
Exploring the Frontiers of Genetic ResearchRUSSIAN JOURNAL OF GENETICS is a significant platform in the field of genetics, published by PLEIADES PUBLISHING INC since its inception in 1996. With an ISSN of 1022-7954 and an E-ISSN of 1608-3369, the journal focuses on a wide array of topics within genetics, providing researchers, professionals, and students with insights into advancements and discoveries in this ever-evolving discipline. While it currently holds a Q4 ranking in the 2023 Genetics category according to Scopus, representing invaluable opportunities for knowledge dissemination, the journal is actively working to enhance its impact in future rankings. Readers will find the journal a repository of diverse genetic research findings, methodologies, and theoretical advancements. Although it is not an open-access journal, it is committed to serving the academic community through rigorous peer-reviewed articles. With a consistent publication trajectory spanning to 2024, the RUSSIAN JOURNAL OF GENETICS remains a crucial resource for those aspiring to stay at the forefront of genetic research and applications.
Frontiers in Aging
Unraveling the Complexities of Aging TogetherFrontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.
JOURNAL OF CELLULAR PHYSIOLOGY
Advancing the Frontiers of Cellular KnowledgeJOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.
BIOLOGICHESKIE MEMBRANY
Advancing Knowledge on Biological MembranesBIOLOGICHESKIE MEMBRANY is a critical journal in the field of Cell Biology and Molecular Biology, published by MEZHDUNARODNAYA KNIGA in the Russian Federation. With an ISSN of 0233-4755, this journal has been serving the academic community since 1996 and continues to publish cutting-edge research that advances our understanding of biological membranes and their functions. Despite being classified in Q4 quartiles for both Cell and Molecular Biology in the 2023 category rankings, the journal presents a unique platform for emerging research within these pivotal areas. Researchers, professionals, and students alike will find valuable insights in its pages as it seeks to foster a collaborative environment that encourages knowledge sharing. Although currently not available as an open-access journal, it remains an essential resource for those looking to deepen their knowledge and contribute to ongoing discussions in the biological sciences. The journal’s commitment to publishing quality research is underscored by its continuous coverage until 2024, making it a sustained reference in the field.